SUPPLEMENTARY INFORMATION:

This meeting is held under the provisions of chapter 10 of title 5, United States Code (U.S.C.) (commonly known as the Federal Advisory Committee Act or FACA) and 41 Code of Federal Regulations (CFR) 102-3.140 and 102-3.150.

Due to circumstances beyond the control of the Designated Federal Officer and the Department of War, the Uniform Formulary Beneficiary Advisory Panel was unable to provide public notification required by 41 CFR 102-3.150(a) concerning its June 22, June 23, and June 24, 2026, meetings. Accordingly, the Advisory Committee Management Officer for the Department of War, pursuant to 41 CFR 102-3.150(b), waives the 15-calendar day notification requirement.

Purpose of the Meeting: The UFBAP will review and comment on recommendations made by the Pharmacy and Therapeutics Committee to the Director, Defense Health Agency regarding the Uniform Formulary.

Agenda

1. 10:00 a.m.-10:10 a.m. Sign in for UFBAP members

2. 10:10 a.m.-10:40 a.m. Welcome and Opening Remarks

a. Welcome, Opening Remarks, and Introduction of UFBAP Members by CAPT Phung Thien Nguyen, DFO, UFBAP

b. Public Written Comments by CAPT Phung Thien Nguyen, ADFO, UFBAP

c. Opening Remarks by Jon Ostrowski, UFBAP Member

d. Introductory Remarks by Dr. Edward Vonberg, Chief, Formulary Management Branch

3. 10:40 a.m.-11:45 a.m. Scheduled Therapeutic Class Reviews

4. 11:45 a.m.-12:30 p.m. Newly Approved Drugs Review

5. 12:30 p.m.-12:45 p.m. Pertinent Utilization Management Issues

6. 12:45 p.m.-1:00 p.m. Closing remarks

a. Closing Remarks by UFBAP Co-Chair

b. Closing Remarks by ADFO, UFBAP

Meeting Accessibility: Pursuant to section 1009(a)(1) of title 5, U.S.C. and 41 CFR 102-3.140 through 102-3.165, and subject to the availability of phone lines, the meeting is open to the public. Telephone lines are limited and available to the first 220 people dialing in. There will be 220 lines total: 200 domestic and 20 international, including leader lines.

Written Statements: Pursuant to 41 CFR 102-3.105(j) and 102-3.140(c), and section 1009(a)(3) of title 5, U.S.C., interested persons or organizations may submit written statements to the UFBAP about its mission and/or the agenda to be addressed in the public meetings. Written statements should be submitted to UFBAP's ADFO. The ADFO's contact information can be found in the FOR FURTHER INFORMATION CONTACT section of this notice. Written comments or statements received are releasable to the public. The DFO will review all submitted written statements and provide copies to UFBAP.

91 FR 47227